Summary
The effects of acute intravenous administration of synthetic DSIP, 25 nmoles/kg b. wt, on disturbed human sleep were tested in 6 middle-aged chronic insomniacs. The results were: longer sleep duration and a higher quality of sleep with fewer interruptions; slightly more REM-sleep, but no day-time sedation or other side effects though the sleep enhancing capacity was seen for up to 6 h of night sleep. Sleep-promoting effects occurred only in the second hour after injection, in the first hour a slight arousing effect was indicated. The study corroborates the findings of previous investigations in healthy subjects and shows that DSIP has a normalizing influence on human sleep regulation.
Similar content being viewed by others
References
Blois R., Monnier M., Schoenenberger G.A., Tissot R., and Gaillard J.-M., 1980. Effect of DSIP on diurnal and nocturnal sleep in man. 5th Eur. Sleep Congr., Amsterdam. Abstracts, p. 16.
Gnirss F., Schneider-Helmert, D., Schenker J., Tobler H.J., and Schoenenberger G.A., 1980. Pilot study on the sleep inducing capacity of DSIP in humans. Sleep Res.9, 51.
Graf M., Monnier M., Schneider-Helmert D., and Schoenenberger G.A. 1980. DSIP: A circadian ‘pace-maker’? In: Progress in Neuro-Pharmacology, p. 251. Ed. Radouco-Thomas C., Garcia F. Pergamon Press, Oxford-New York-Toronto-Sydney-Paris-Frankfurt.
Graf M., Christen H., Tobler H.J., Baumann, J.B., and Schoenenberger G.A., 1981. DSIP — A circadian ‘programming’ substance? Experientia37, 22.
Graf M., Lorez H.P., Gillesen D., Tobler H.J., and Schoenenberger G.A., 1981. Distribution and specific binding of3H-DSIP. Experientia37, 23.
Hoddes E., Zarcone V., Smythe H., Phillips R., and Dement W. C., 1973. Quantification of sleepiness: a new approach. Psychophysiology10, 431.
Huang J.-T., and Lajtha A., 1978. The degradation of a nonapeptide, sleep-inducing-peptide, in rat brain: comparison with enkephalin breakdown. Res. Commun. chem. Path. Pharm.19, 191.
Janke W., and Debus G., 1978. Die Eigenschaftswörterliste-EWL. Hogrefe, Göttingen-Toronto-Zürich.
Kafi S., Monnier M., and Gaillard J.-M., 1979. The delta-sleep-inducing-peptide (DSIP) increases duration of sleep in rats. Neurosci. Lett.13, 169.
Kastin A.J., Nissen C., Schally A.V., and Coy D.H., 1978. Radioimmuno-assay of DSIP-like material in rat brain. Brain Res. Bull.3, 691.
Kastin A.J., Nissen C., Schally A.V., and Coy D.H., 1979. Additional evidence that small amounts of a peptide can cross the blood-brain barrier. Pharmac. Biochem. Behav.11, 717.
Kastin A.J., Olson G.A., Schally A.V., and Coy D.H., 1980. DSIP — more than a sleep peptide? TINS25, 163.
Marks N., Stern F., Kastin A.J., and Coy D.H., 1977. Degradation of delta-sleep-inducing-peptide (DSIP) and its analogs by brain extracts. Brain Res. Bull.2, 491.
Monnier M., Dudler L., Gächter R., Maier P.F., Tobler H.J., and Schoenenberger G.A., 1977. The delta-sleep-inducing-peptide (DSIP). Comparative properties of the original and synthetic nonapeptide. Experientia33, 548.
Monnier M., Hatt A.M., Cueni L.B., and Schoenenberger G.A., 1972. Humoral transmission of sleep. VI. Purification and assessment of a hypnogenic fraction of ‘sleep dialysate’; factor delta. Pflügers Arch.331, 257.
Monnier M., and Hösli L. 1965. Humeral transmission of sleep and wakefulness. II. Hemodialysis of sleep inducing humor during stimulation of the thalamic hypnogenic area. Pflügers Arch.282, 60.
Nagasaki H., Kitahama K., Valatx J.-L., and Jouvet M., 1980. Sleep-promoting effect of the sleep-promoting substance (SPS) and delta-sleep-inducing-peptide (DSIP) in the mouse. Brain Res.192, 276.
Polc P., Schneeberger J., and Haefely W., 1978. Effect of the delta-sleep-inducing-peptide (DSIP) on the sleep-wakefulness cycle of cats. Neurosci. Lett.9, 33.
Rechtschaffen A., and Kales A., eds, 1968. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institute of Health, Washington/USA
Scherschlicht R., 1990. Zwölf Jahre Schlafforschung: Ein Erkenntnisstand-Vergleich. Roche Magazin9, 4.
Scherschlicht R., Schneeberger J., Steiner M., and Haefely W., 1979. Delta-sleep-inducing-peptide antagonizes morphine insomnia in cats. Sleep Res.8, 84.
Schneider-Helmert D., Gnirss F., Monnier M., Schenker J., and Schoenenberger G.A., 1981. Acute and delayed effects of DSIP (delta-sleep-inducing-peptide) on human sleep behavior. Clin Pharmac., in press.
Schneider-Helmert D., 1981. Clinical and conceptual aspects of sleep and emotional stress, in: Sleep 1980, Proc. 5th Eur. Congr. Sleep Research. Karger, Basel, in press.
Schoenenberger G.A., Maier P.F., Tobler H.J., and Monnier M., 1977. A naturally occurring delta-EEG enhancing nonapeptide in rabbits. X. Final isolation, characterization and activity test. Pflügers Arch.369, 99.
Schoenenberger G.A., Maier P.F., Tobler H.J., Wilson K., and Monnier M., 1978. The delta-EEG-(sleep)-inducing-peptide (DSIP). XI. Amino acid analysis, sequence, synthesis and activity of the nonapeptide. Pflügers Arch.376, 119.
Schoenenberger G.A., and Monnier M., 1977. Characterization of a delta-electroencephalogramm-(sleep)-inducing-peptide. Proc. natl Acad. Sci.74, 1282.
Schoenenberger G.A., and Monnier M., 1979. Studies on the delta-(sleep)-inducing-peptide, in: IUPAC Medical Chemistry Proceedings, p. 101. VIth Int. Symp. Med. Chem., Brighton 1978. Cotwold Press, Oxford.
Williams R.L., Karacan I., and Hursch C.J., 1974. EEG of human sleep: Clinical applications. John Wiley & Sons. New York-London-Sydney-Toronto.
Yehuda S., Kastin A.J. and Coy D.H., 1980. Thermoregulatory and locomotor effects of DSIP: Paradoxical interactions with D-amphetamine. Pharmac. Biochem. Behav.13, 895.
Author information
Authors and Affiliations
Additional information
In honor of W. R. Hess, to mark the centenary of his birth.
Editorial foreword. Experimental work in the field of sleep research was energetically furthered by the efforts of the eminent physiologist and Nobel Laureate Walter Rudolf Hess, in whose memory the Zürich lecture series ‘The Principle of Order in Physiology’ was held on March 14th, 1981. The following report documents the first controlled clinical experiments testing the delta-sleep-inducing-peptide on chronic sufferers of insomnia. In order that these findings may reach as wide a readership as possible, we are placing this brief but important report under the heading ‘Generalia’.
Rights and permissions
About this article
Cite this article
Schneider-Helmert, D., Schoenenberger, G.A. The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep. Experientia 37, 913–917 (1981). https://doi.org/10.1007/BF01971753
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01971753